Within your Trust how many unique patients with Advanced Prostate Cancer (C61X) have been treated in the past 12 months? 942
How many patients with Advanced Prostate Cancer have received?
| Abiraterone (Zytiga) | |
| Cabazitaxel (Jevtana) | |
| Docetaxel (Taxotere) | |
| Enzalutamide (Xtandi) | |
| Radium-223 (Xofigo) | |
| Bicalutamide (Casodex) |
Within your trust how many unique patients with Differentiated Non-Medullary Thyroid Cancer (C73X) have been treated in the past 12 months? 121
How many patients with with Differentiated Non-Medullary Thyroid Cancer have received?
| Axitinib (Inlyta) | |
| Cabozantinib (Cometriq) | |
| Pazopanib (Votrient) | |
| Sorafenib (Nexavar) | |
| Sunitinib (Sutent) | |
| Vandetanib (Caprelsa) |
Within your trust how many unique patients with Hepatocellular Carcinoma (C220) have been treated in the past 12 months? 38
How many patients with with Hepatocellular Carcinoma have received?
| Bevacizumab (Avastin) | |
| Everolimus (Afinitor) | |
| Lapatinib (Tyverb) | |
| Sorafenib (Nexavar) | |
| Sunitinib (Sutent) |
Within your trust how many unique patients with Gastrointestinal Stromal Tumours (C269) have been treated in the past 12 months? 16
How many patients with with Gastrointestinal Stromal Tumours have received?
| Dasatinib (Sprycel) | |
| Imatininb (Glivec) | |
| Nilotinib (Tasigna) | |
| Pazopanib (Votrient) | |
| Regorafenib (Stivarga) | |
| Sorafenib (Nexavar) | |
| Sunitinib (Sutent) |
The data below indicates the number of individual patients issued with each of the drugs requested. However, the Trust is unable to align each medicine to the condition because one drug can be used for a range of cancer diagnoses and the Pharmacy dispensing system does not record the indication for treatment.
To obtain this information the Trust would need to interrogate individual healthcare records and, therefore, the cost of compliance would exceed the appropriate limit under Section 12 of the Freedom of Information Act.
| DRUG | Patients |
| ABIRATERONE | 83 |
| AXITINIB | 23 |
| BEVACIZUMAB | 132 |
| BICALUTAMIDE | 104 |
| CABAZITAXEL | 9 |
| DASATINIB | 2 |
| DOCETAXEL TRIHYDRATE | 436 |
| ENZALUTAMIDE | 76 |
| EVEROLIMUS | 23 |
| IMATINIB | 35 |
| LAPATINIB | 4 |
| NILOTINIB | 6 |
| PAZOPANIB | 48 |
| SORAFENIB | 9 |
| SUNITINIB | 44 |
| VEMURAFENIB | 2 |